Orthopedic fixation company, Ossio, won the 2019 Frost & Sullivan North America New Product Innovation Award for its bone regeneration device, Ossiofiber.

Regenerative medicine and cell therapy company InGeneron extended its Series D financing by up to $23 million, totaling $43 million, to be invested in the company.

Konica Minolta Healthcare is hosting an autologous biologics workshop in collaboration with EmCyte to support education for ultrasound-guided musculoskeletal inventions.

Bioventus has partnered with MTF Biologics to co-develop a placental tissue product for the treatment of painful musculoskeletal conditions, focusing initially on knee osteoarthritis.

Scottsdale, Ariz.-based R3 Stem Cell responded to an FDA letter that raised safety and legality concerns over R3's stem cell offerings.

A federal judge granted the FDA authority to regulate treatments from U.S. Stem Cell Clinic and U.S. Stem Inc., NBC News reports.

Niagara Falls (N.Y.) Memorial Medical Center and Andrew Cappuccino, MD, of Buffalo (N.Y.) Spine Surgery are opening a stem cell therapy center, reports WNY Papers.com.

A new study published in The Spine Journal examines outcomes from posterior lumbar fusions at a physician-owned hospital compared with a non-physician-owned hospital. 

Atlanta-based Emory Orthopedics & Spine Center's Ken Mautner, MD, is studying how three different stem cell therapies treat osteoarthritis, local news affiliate Fox 5 reports. 

A new study published in The Spine Journal examines long-term data on the risk for cancer associated with recombinant human bone morphogenetic protein use in spinal fusions.

A new study published in Spine examines 30- and 90-day readmission rates for spinal fusions.

Clinical stage regenerative medicine company, SpinalCyte, now features research studies on its website outlining the potential benefits of fibroblast technology.

Fort Collins, Colo.-based bioavailable cannabis solutions company, Geocann, hired Anthony Petraglia, MD, as CMO, and chairman of the Scientific and Medical Advisory Board.

Five spine surgeons discuss where they expect technology to evolve over the next half-decade.

A new study published in Spine examines bone graft substitutes for one- and two-level anterior cervical discectomy and fusion.

Vail, Colo.-based Steadman Clinic's Matthew Provencher, MD, received AlloSource's Dr. Steven Gitelis Inspiration Award to recognize his work using donated human tissue to help patients heal.

Marietta, Ga.-based biopharmaceutical company MiMedx has appointed Timothy Wright as its new CEO.

Orthopedic surgeon at San Diego-based Grossmont Hospital Scott A. Hacker, MD, treated the first four patients in the west coast with medical device company CartiHeal's Agili-C cartilage regeneration implant.

San Antonio-based nonprofit BioBridge Global has added orthopedic surgeon Michael J. Yaszemski, MD, PhD, to its regenerative medicine advisory board.

New York-based medical device manufacturer Misonix agreed to acquire privately held wound-healing company Solys Medical of Newport News, Va., in an all-stock transaction valued at $97 million.